Patients with LN who started life with a low number of nephrons, or have nephron loss beyond physiologic aging, have a shorter renal life span, especially in aging populations
In another report, a 26week treatment with the GLP1R/GIPR dual agonist LY3298176 (Tirzepatide, Eli Lilly), showed significant reduction in A1c in an incremental, dosedependent manner (4 doses from 1 mg to 15 mg, A1c reduction from 1.06% to 1.94% respectively)
The email arrived at 515
A drop in metabolic rate if muscle mass has decreased Emotional eating triggered by withdrawal-like changes in mood or reward processing For many, it is likely that GLP-1 medications will be needed long-term alongside lifestyle and behavioural changes
The Energy Enhancers (Foods 26-35) Fighting GLP-1 fatigue
Ternesten-Hassus E, Johansson EL, Millqvist E (2024) Oral capsaicin as treatment for unexplained chronic cough and airway symptoms